Klaus Wilms

479 total citations
13 papers, 330 citations indexed

About

Klaus Wilms is a scholar working on Pathology and Forensic Medicine, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Klaus Wilms has authored 13 papers receiving a total of 330 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pathology and Forensic Medicine, 5 papers in Pulmonary and Respiratory Medicine and 4 papers in Oncology. Recurrent topics in Klaus Wilms's work include Lymphoma Diagnosis and Treatment (5 papers), Gastric Cancer Management and Outcomes (4 papers) and Gastrointestinal Tumor Research and Treatment (3 papers). Klaus Wilms is often cited by papers focused on Lymphoma Diagnosis and Treatment (5 papers), Gastric Cancer Management and Outcomes (4 papers) and Gastrointestinal Tumor Research and Treatment (3 papers). Klaus Wilms collaborates with scholars based in Germany, Austria and Australia. Klaus Wilms's co-authors include Wolfgang Fischbach, Andreas Greiner, O. Horstmann, Qin Yang, Hans–Konrad Müller–Hermelink, E. Dühmke, Christian Ohmann, Martin Busch, P. R. Verreet and B Dragosics and has published in prestigious journals such as Blood, Gastroenterology and Cancer.

In The Last Decade

Klaus Wilms

13 papers receiving 313 citations

Peers

Countries citing papers authored by Klaus Wilms

Since Specialization

Citations

This map shows the geographic impact of Klaus Wilms's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Klaus Wilms with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Klaus Wilms more than expected).

Fields of papers citing papers by Klaus Wilms

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Klaus Wilms. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Klaus Wilms. The network helps show where Klaus Wilms may publish in the future.

Co-authorship network of co-authors of Klaus Wilms

This figure shows the co-authorship network connecting the top 25 collaborators of Klaus Wilms. A scholar is included among the top collaborators of Klaus Wilms based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Klaus Wilms. Klaus Wilms is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

#	Work	Indexed citations
1	Rituximab Maintenance Prolongs Response Duration after Salvage Therapy with R-FCM in Patients with Relapsed Follicular Lymphomas and Mantle Cell Lymphomas: Results of a Prospective Randomized Trial of the German Low Grade Lymphoma Study Group (GLSG). 2005 ·Blood ·Wolfgang Hiddemann, Roswitha Forstpointner, Martin Dreyling, Martin Gramatzki, (unknown), Mathias Hänel, John F. Seymour, M. Planker, Ulrich Dührsen, Klaus Wilms, (unknown), Wolf‐Dieter Ludwig, Hannes Wandt, R. Pasold, Michael Unterhalt	6
2	Long-term results of the German-Austrian prospective multicenter study in 236 patients with localized primary gastric B-cell lymphoma 2001 ·Gastroenterology ·Wolfgang Fischbach, (unknown), (unknown), B Dragosics, Andreas Greiner, Christian Ohmann, (unknown), Martin Busch, Klaus Wilms	3
3	Primary gastric B-Cell lymphoma: Results of a prospective multicenter study 2000 ·Gastroenterology ·Wolfgang Fischbach, B Dragosics, (unknown), Christian Ohmann, Andreas Greiner, Qin Yang, Stephan Böhm, P. R. Verreet, O. Horstmann, Martin Busch, E. Dühmke, Hans–Konrad Müller–Hermelink, Klaus Wilms	151
4	Differences in endoscopic and clinicopathological features of primary and secondary gastric non-Hodgkin's lymphoma 1999 ·Gastrointestinal Endoscopy ·(unknown), Wolfgang Fischbach, Andreas Greiner, Klaus Wilms	42
5	Image Analysis Detects Lineage-Specific Morphologic Markers in Leukemic Blast Cells 1996 ·American Journal of Clinical Pathology ·Irith Baumann, (unknown), Harry Harms, H. Zwierzina, Klaus Wilms, Alfred C. Feller, Volker ter Meulen, H. K. Müller-Hermelink	16
6	Malignant lymphomas of the upper gastrointestinal tract. Results of a prospective study in 103 patients 1992 ·Cancer ·Wolfgang Fischbach, (unknown), T Kirchner, Joachim Mössner, Klaus Wilms	45
7	Nuclear Topoisomerase II Activity Changes During HL-60 Leukemic Cell Differentiation: Alterations in Drug Sensitivity and pH Dependency 1991 ·Leukemia & lymphoma ·Frank Gieseler, Fritz Boege, Harald Biersack, (unknown), Michael J. Clark, Klaus Wilms	4
8	Granulocytic differentiation of HL-60 cells is not regulated by DNA de novo methylation 1989 ·Annals of Hematology ·Frank Gieseler, Peter Meyer, Dietmar Schiffmann, Klaus Wilms	7
9	Mitoxantrone metabolism in the isolated perfused rat liver 1984 ·Cancer Chemotherapy and Pharmacology ·Gerhard Ehninger, Barbara Proksch, Franz Hartmann, (unknown), Klaus Wilms	20
10	Immunohistology of graft-versus-host disease mediated skin lesions and its correlation to a large granular lymphocyte surface phenotype and function 1982 ·Annals of Hematology ·(unknown), (unknown), Graham Pawelec, Klaus Wilms, Peter Wernet	12
11	Proliferationshemmung der AKR-M�useleuk�mie in vivo mit Kalbsmilzextrakt (Lymphozytenchalon) 1977 ·Annals of Hematology ·E. Heidemann, (unknown), (unknown), (unknown), Klaus Wilms, (unknown)	4
12	Photooxidation of Annulenes 1974 ·Angewandte Chemie International Edition in English ·Emanuel Vogel, (unknown), Klaus Wilms	10
13	Photooxidation von Annulenen 1974 ·Angewandte Chemie ·Emanuel Vogel, (unknown), Klaus Wilms	10

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact